Skip to content
Screener

Jazz Pharmaceuticals JAZZ Payments to Acquire Property, Plant, and Equipment

Payments to Acquire Property, Plant, and Equipment at other companies

Amgen logo
AmgenAMGN
$513M+39.0%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$5.09M+1,613%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
ResMed logo
ResMedRMD

Other financials

Income statement

See full
Revenue$1.1B+19.1%
Operating income$336.6M+702%
Net income$293.1M+417%
EPS (diluted)$4.43+391%

Balance sheet

See full
Cash & equivalents$667.5M-64.1%
Total debt$5.4B-0.1%
Total equity$4.5B+8.6%
Total assets$11.9B+2.8%

Cash flow

See full
Operating cash flow$408.2M-5.0%
CapEx$19.7M+41.7%
Free cash flow$388.5M-6.6%

Valuation

See full
Market cap$16.65B+148%
Enterprise value$21.39B+95.4%
P/S3.8×+2.1×

Profitability

See full
Operating margin-11.9%-28.1pp
Net margin-8.9%-20.5pp
FCF margin28.6%-8.6pp

Returns & leverage

See full
Return on equity-9.1%-21.2pp
Debt / equity1.2×-0.1×
Current ratio-1.3×

Where this comes from

Reported directly by Jazz Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The source filing: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 4:09 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001232524-26-000025
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Proceeds from maturity of investments520.0310.0
Proceeds from sale of priority review voucher200.0
Payments related to sale of priority review voucher(77.2)
Purchases of property, plant and equipment(19.7)(13.9)
Acquisition of investments(500.0)(440.1)
Acquisition of intangible assets(25.0)
Net cash provided by (used in) investing activities123.1(169.0)
Financing activities

Item 1.Financial Statements

FAQ

What is Jazz Pharmaceuticals's payments to acquire property, plant, and equipment?
Jazz Pharmaceuticals (JAZZ) reported payments to acquire property, plant, and equipment of $19.7M in Q1 2026.
How has Jazz Pharmaceuticals's payments to acquire property, plant, and equipment changed year-over-year?
Jazz Pharmaceuticals's payments to acquire property, plant, and equipment increased by 41.7% year-over-year, from $13.9M to $19.7M.
What is the long-term trend for Jazz Pharmaceuticals's payments to acquire property, plant, and equipment?
Over 3 years (2021 to 2025), Jazz Pharmaceuticals's payments to acquire property, plant, and equipment has grown at a 28.6% compound annual growth rate (CAGR), from $27.64M to $58.75M.
What does payments to acquire property, plant, and equipment mean?
Cash outflows for the purchase of physical assets, including machinery, facilities, and equipment, necessary for ongoing operations. This represents the core capital investment required to maintain or expand production capacity.

Ask your AI about Jazz Pharmaceuticals's payments to acquire property, plant, and equipment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude